Company Filing History:
Years Active: 2024
Title: Penrose Odonnell: Innovator in Transplantation Technology
Introduction
Penrose Odonnell is a notable inventor based in Yarmouth, ME (US). He has made significant contributions to the field of transplantation through his innovative research and patented technologies. His work focuses on enhancing the immunocompatibility of donor cells, which is crucial for successful transplantation procedures.
Latest Patents
Penrose Odonnell holds a patent for "CRISPR/Cas-related methods and compositions for improving transplantation." This patent discloses compositions and methods aimed at increasing the immunocompatibility of donor cells, such as hematopoietic stem cells (HSCs) or T-cells, for transplantation to recipient subjects. The methods described result in the allele-specific modification of immunogenicity genes, such as HLA genes, making the cells suitable for transplantation.
Career Highlights
Odonnell is currently associated with Editas Medicine, Inc., where he continues to advance his research in gene editing and transplantation technologies. His work is pivotal in developing new methods that could revolutionize the field of organ transplantation.
Collaborations
Some of his notable coworkers include Jennifer Leah Gori and Tongyao Wang, who collaborate with him on various research projects aimed at improving transplantation outcomes.
Conclusion
Penrose Odonnell's innovative work in transplantation technology, particularly through his patented methods, showcases his commitment to enhancing medical practices. His contributions are expected to have a lasting impact on the field of transplantation.